NHC Key Laboratory of Tropical Disease Control, Hainan Medical University, Haikou, China.
Hainan Women and Children' Medical Center, Haikou, China.
J Clin Lab Anal. 2022 Mar;36(3):e24260. doi: 10.1002/jcla.24260. Epub 2022 Feb 4.
Hainan has one of the high incidences of thalassemia in China, but the epidemiological data in the whole province has not been reported yet. The objective of our study was to reveal the true prevalence and molecular mutation spectrum of thalassemia in the population of Hainan who are of childbearing age.
We screened 166,936 individuals from 19 cities and counties in Hainan by hematological parameters analysis, and further conducted genetic analysis for individuals whose MCV was less than 82fL.
In total, 21,619 (12.95%) subjects were diagnosed as thalassemia carriers or patients. The overall prevalence of α-thalassemia, β-thalassemia, and α+β-thalassemia were 10.39%, 1.38%, and 1.18%, respectively. Eleven α-thalassemia mutations and sixteen β-thalassemia mutations were identified. The high-frequent genotypes of α-thalassemia were -α /αα (19.70%), -α /αα (19.39%), αα/-- (15.60%), α α/αα (9.24%), and -α /-α (8.90%), and those of β-thalassemia were β /β (58.92%), β /β (16.05%), β /β (8.42%), β /β (6.03%), β /β (5.47%), and β /β (2.69%). In addition, the frequencies and hematological profiles of many rare mutations of α- [Fusion, HKαα, αααanti , IVS-II-55 (T>G), IVS-II-119 (-G,+CTCGGCCC)] and β-globin genes [-50 (G>A), IVS-Ⅱ-81 (C>T)] in Hainan were reported for the first time.
Our study revealed the high prevalence and extensive molecular spectrum of thalassemia in childbearing age population of Hainan, suggesting thalassemia in Hainan ranks second in prevalence among all regions in China. The findings will be useful for genetic counseling and prevention of thalassemia.
海南是中国地中海贫血发病率较高的地区之一,但全省的流行病学数据尚未报道。本研究的目的是揭示海南省育龄人群中地中海贫血的真实患病率和分子突变谱。
我们通过血液学参数分析对来自海南省 19 个市县的 166936 人进行了筛查,对 MCV 小于 82fL 的个体进一步进行了基因分析。
共有 21619 名(12.95%)个体被诊断为地中海贫血携带者或患者。α-地中海贫血、β-地中海贫血和α+β-地中海贫血的总患病率分别为 10.39%、1.38%和 1.18%。共发现 11 种α-地中海贫血突变和 16 种β-地中海贫血突变。α-地中海贫血的高频基因型为-α/αα(19.70%)、-α/αα(19.39%)、αα/-(15.60%)、αα/αα(9.24%)和-α/-α(8.90%),β-地中海贫血的高频基因型为β/β(58.92%)、β/β(16.05%)、β/β(8.42%)、β/β(6.03%)、β/β(5.47%)和β/β(2.69%)。此外,本研究首次报道了海南省α-珠蛋白基因[融合、HKαα、ααα抗、IVS-II-55(T>G)、IVS-II-119(-G,+CTCGGCCC)]和β-珠蛋白基因[-50(G>A)、IVS-Ⅱ-81(C>T)]许多罕见突变的频率和血液学特征。
本研究揭示了海南省育龄人群地中海贫血的高患病率和广泛的分子谱,提示海南省地中海贫血的患病率在中国所有地区中排名第二。研究结果将有助于遗传咨询和地中海贫血的预防。